---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-056571"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T01:12:23.457472+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Denali Capital terminates business combination with Longevity Biomedical; SPAC seeks new target

## Summary
- Merger agreement terminated effective June 26, 2024, by mutual agreement of Denali and Longevity Biomedical.
- Original merger agreement was entered January 25, 2023; no reason for termination specified.
- Denali and its sponsor will pursue alternative initial business combination; S-4 registration to be withdrawn.
- Ancillary agreements also automatically terminate; certain customary survival provisions remain.

## SEC filing metadata
- accession: 0001213900-24-056571
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390024056571/0001213900-24-056571-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390024056571/ea0208645-8k_denali.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-056571
- JSON: https://secwatch.observer/filing/0001213900-24-056571.json
- Plain text: https://secwatch.observer/filing/0001213900-24-056571.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.